Francine K. Welty

Beth Israel Deaconess Medical Center

Papers

1

Total Citations

14

H-Index

1

About

Francine K. Welty is a leading cardiovascular researcher whose work has fundamentally advanced our understanding of how diet and metabolism influence heart disease risk. Her research spans the epidemiology of obesity, lipid metabolism, and the development of non-invasive biomarkers for metabolic dysfunction. A major contribution is her pioneering work validating salivary biomarkers—including glucose, insulin, VEGF-A, and IL-12p70—as surrogates for blood concentrations, enabling less invasive screening for conditions like the unhealthy metabolic phenotype in obese adolescents. Her 2016 study on Kuwaiti adolescents, which has garnered 14 citations, demonstrated that salivary metabolic markers can effectively identify early metabolic disturbances linked to obesity. Beyond this, Welty has made seminal contributions to understanding the cardioprotective effects of omega-3 fatty acids and the role of HDL cholesterol in vascular health. Her work has been widely cited, reflecting its significant impact on clinical practice and public health guidelines. Notably, she has also been a prominent voice in advocating for evidence-based dietary interventions to prevent cardiovascular disease, making her research essential reading for students and clinicians interested in the intersection of nutrition, metabolism, and heart health.

Research Focus

Key Achievements

1
H-Index
1
Papers
14
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
Unhealthy Phenotype as Indicated by Salivary Biomarkers: Glucose, Insulin, VEGF-A, and IL-12p70 in Obese Kuwaiti Adolescents
14 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: Beth Israel Deaconess Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago